Trials / Recruiting
RecruitingNCT05097586
RCT of At-Home tDCS for Depression in Pregnancy
Randomized Controlled Trial of At-home Transcranial Direct Current Stimulation (tDCS) for Depression in Pregnancy
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 156 (estimated)
- Sponsor
- Women's College Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, sham-controlled trial to determine whether treatment with transcranial direct current stimulation (tDCS) is superior to a sham condition at reducing the symptoms of depression in pregnant people with moderate to severe depression. The study aims to enrol 156 participants across all sites. Data collection occurs at baseline, immediately after treatment, every 4 weeks during pregnancy and 4-, 12-, 26- and 52-weeks postpartum
Detailed description
Transcranial direct current stimulation (tDCS) is a brain stimulation technique for the treatment of depression that has great potential for filling the gap in treatment options for moderate and severe depression in pregnancy. Participants are randomized 1:1 to active tDCS treatment or sham control. After at least one in-person training session with the research team, participants take the tDCS device home and self-administer 30-minute treatments 5 times per week, for 3 weeks, for a total of 15 sessions. Rater-administered and self-report outcomes are collected weekly during the 3-week active treatment phase, every 4 weeks during pregnancy, and at 4-, 12-, 26- and 52-weeks postpartum. A mixed methods process evaluation is embedded into the trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | active tDCS | 2mA of direct current delivered in 15 sessions lasting 30 minutes each over 3 weeks |
| OTHER | workbook | Self-directed depression in pregnancy workbook completed during each session to control the in-session brain state |
| DEVICE | sham tDCS | Sham stimulation in which the current turns off after 30 seconds in a slow ramp down that mirrors sensory adaptation in ongoing stimulation, delivered in 15 sessions lasting 30 minutes each over 3 weeks |
Timeline
- Start date
- 2021-11-08
- Primary completion
- 2026-01-31
- Completion
- 2027-06-01
- First posted
- 2021-10-28
- Last updated
- 2025-05-28
Locations
2 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT05097586. Inclusion in this directory is not an endorsement.